59081-61-7

Basic information

• Product Name: CHEMBRDG-BB 4140261
• Synonyms: CHEMBRDG-BB 4140261;2-METHYL-N-PHENYLALANINE;2-methyl-N-phenylalanine(SALTDATA: FREE);Alanine, 2-Methyl-N-phenyl-
• CAS NO: 59081-61-7
• Molecular Formula: C₁₀H₁₃NO₂
• Molecular Weight: 179.22
• Mol File: 59081-61-7.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 355.5°C at 760 mmHg
• Flash Point: 168.8°C
• Appearance: /
• Density: 1.17g/cm³
• Vapor Pressure: 1.14E-05mmHg at 25°C
• Refractive Index: 1.584
• Storage Temp.: Refrigerator, under inert atmosphere
• Solubility: DMSO (Slightly), Methanol (Slightly)
• CAS DataBase Reference: CHEMBRDG-BB 4140261(CAS DataBase Reference)
• NIST Chemistry Reference: CHEMBRDG-BB 4140261(59081-61-7)
• EPA Substance Registry System: CHEMBRDG-BB 4140261(59081-61-7)

Safety Data

• Hazardous Substances Data: 59081-61-7(Hazardous Substances Data)

Usage

General Description

CHEMBRDG-BB 4140261, also known as (Z)-2-(2-((3-ethyl-4-(3-(3-ethyl-4-hydroxy-5-((3-ethyl-4-methoxybenzyl)oxy)-6-methyltetrahydro-2H-pyran-2-yl)phenyl)benzofuran-2-yl)ethynyl)phenoxy)-N-(4-methoxybenzylidene)ethanamine, is a complex chemical compound with a long molecular formula. It consists of various functional groups including ethyl, hydroxy, methoxy, benzyl, and amine groups. It is commonly used in pharmaceutical research and drug discovery as it may have potential therapeutic effects in various diseases and conditions. However, further studies and research are needed to fully understand its biological activities and potential applications.

InChI:InChI=1/C10H13NO2/c1-10(2,9(12)13)11-8-6-4-3-5-7-8/h3-7,11H,1-2H3,(H,12,13)

Upstream product

• 600-00-0 ethyl 2-bromoisobutyrate 
• 62-53-3 aniline 
• 75997-06-7 3'-phenyl-4',4'-dimethylxanthene-9-spiro-2'-oxazolidin-5'-one 
• 591-50-4 iodobenzene 
• 62-57-7 2-Aminoisobutyric acid 
• 108-86-1 bromobenzene 
• 142-04-1 aniline hydrochloride 
• 586-96-9 Nitrosobenzene 
• 7647-01-0 hydrogenchloride 
• 74262-30-9 2-methyl-N-phenyl-2-(phenylamino)propanamide 
• 99940-45-1 C₁₆H₂₉NO₃Si₂ 
• 14839-73-7 2-<α-Anilino-isobutyrylamino>-propionsaeure-anilid 
• 57-15-8 1,1,1-trichloro-2-methyl-2-propanol 
• 2182-38-9 2-methyl-2-(N-phenylamino)propanenitrile 

Downstream Products

• 62-53-3 aniline 
• 15719-64-9 methylammonium carbonate 
• 67-64-1 acetone 
• 1227476-15-4 Azobenzene 
• 1610875-49-4 tert-butyl 4-(2-methoxy-4-(2-methyl-2-(phenylamino)propanamido)phenyl)-1H-pyrazole-1-carboxylate 
• 1610874-97-9 N-(3-methoxy-4-(1H-pyrazol-4-yl)phenyl)-2-methyl-2-(phenylamino)propanamide 
• 1610875-47-2 N-(4-bromo-3-methoxyphenyl)-2-methyl-2-(phenylamino)propanamide 
• 106272-77-9 3,3,6,6-tetramethyl-4-phenyl-morpholine-2,5-dione 
• 105901-29-9 α-(N-acetyl-anilino)-isobutyric acid 

Relevant articles and documents

Copper-catalyzed: N -(hetero)arylation of amino acids in water

An environmentally benign, mild, cost-effective and gram-scalable copper-catalyzed method for the N-(hetero)arylation of zwitterionic natural and unnatural amino acids using 2-isobutyrylcyclohexanone as a β-diketone ligand and aryl bromides as coupling partners in water for 50 min at 90 °C under microwave irradiation is reported. Electronically and sterically diverse aryl coupling partners were inserted efficiently, including challenging heteroaryl electrophilic partners in high yields without affecting the enantiopurity of the product.

BENZODIAZEPIN-2-ON DERIVATIVES

The present invention relates to a compound represented by the formula(I):wherein R1 represents a hydrogen atom or the like;R2 represents lower alkyl or the like;R3 and R4 represent lower alkyl or the like;R5 represents phenyl or the like;R6 represents a hydrogen atom or the like;m is an integer of from 0 to 2;p is an integer of from 1 to 4; and q is an integer of from 1 to 5, or a pharmaceutical acceptable saltthereof, and a DGAT 1 inhibitor comprising the compound.

Keten. Part 17. Addition Reactions of Ketens with N-Phenyl Nitrones

The N-phenyl nitrones (1a), (4b), and (15) react with ketens in two totally different ways.Triphenylnitrone (4b) forms oxidolones (6) whereas (1a) and (15) form oxazolidinones (2) and (17).The differences appear to be caused by steric interactions in (1a) and (15) which distort the nitrone function and prevent the N-phenyl group adopting the conformation necessary for the oxindole-forming pathway.